NCT00084227View on ClinicalTrials.gov

Azithromycin Plus Chloroquine Versus Atovaquone-Proguanil For The Treatment Of Uncomplicated Plasmodium Falciparum Malaria In South America

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

244

Participants

Timeline

Start Date

July 31, 2004

Study Completion Date

July 31, 2005

Conditions
Malaria, Falciparum
Interventions
DRUG

Azithromycin/Chloroquine

DRUG

Atovaquone/Proguanil

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY